Company / Operating Cash Flow
CLOVER HEALTH INVESTMENTS, CORP. /DE Operating Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$66.9M
FY2025
5-year range
-$282.3M / $34.8M
FY2021-FY2025
Trend
-292.1%
vs FY2024
Sector context
#153 of 163
Health Care
What the data says
Operating Cash Flow changed -292% YoY in FY2025, a notable deviation from the 6-year average annual change of -37%.
Based on SEC 10-K filings.
-$67M in FY2025.
Improved from -$145M to -$67M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 163This company -$66.9M Sector average $1.0B
▼
-106.4% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 292.1% year-over-year.
- Ranks #153 out of 163 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2024.
- Lowest operating cash flow in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$66.9M | -292.1% |
| FY2024 | $34.8M | +124.1% |
| FY2023 | -$144.7M | +29.1% |
| FY2022 | -$203.9M | +27.8% |
| FY2021 | -$282.3M | -138.3% |
| FY2020 | -$118.5M | +25.9% |
| FY2019 | -$159.9M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026